Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.*

GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.

Martinez, et al. Can J Microbiol 2009;55:133-138

* Fem-Dophilus® Function: Oral Probiotic for Natural Vaginal/Urinary Tract Health*
* Fem-Dophilus® Highlights
Clinically-Documented Benefits
25+ Years of Research and Clinical Studies For Vaginal and Urinary Tract Health*
More Than 20 Studies Demonstrating Safety and Efficacy*
Patented Lactobacilli Strains: GR-1® and RC-14®
Prevention Magazine: Top 10 Breakthrough '07

Warnings

o Keep out of reach of children.

o Keep refrigerated.

Suggested Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication

Ingredients: Maltodextrin (non-GMO source), cellulose, magnesium stearate (vegetable source). Capsule consists of hydroxypropylmethylcellulose and titanium dioxide.

No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.